Stage IVC Squamous Cell Carcinoma of the Oropharynx Completed Phase Trials for DB00317 (Gefitinib)

IndicationStatusPhase
DBCOND0029839 (Stage IVC Squamous Cell Carcinoma of the Oropharynx)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00068497Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerTreatment